Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP458969.RAdGbzMcfCa8MZXFzhlhDHmkT_C4uB1T3Q5X79741fic8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP458969.RAdGbzMcfCa8MZXFzhlhDHmkT_C4uB1T3Q5X79741fic8130_assertion type Assertion NP458969.RAdGbzMcfCa8MZXFzhlhDHmkT_C4uB1T3Q5X79741fic8130_head.
- NP458969.RAdGbzMcfCa8MZXFzhlhDHmkT_C4uB1T3Q5X79741fic8130_assertion description "[The ovarian cancer cell lines OvCa3 and A2780 were further used to test the hypothesis that CRH might contribute to the immune privilege of ovarian tumours, by modulating FasL expression on the cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458969.RAdGbzMcfCa8MZXFzhlhDHmkT_C4uB1T3Q5X79741fic8130_provenance.
- NP458969.RAdGbzMcfCa8MZXFzhlhDHmkT_C4uB1T3Q5X79741fic8130_assertion evidence source_evidence_literature NP458969.RAdGbzMcfCa8MZXFzhlhDHmkT_C4uB1T3Q5X79741fic8130_provenance.
- NP458969.RAdGbzMcfCa8MZXFzhlhDHmkT_C4uB1T3Q5X79741fic8130_assertion SIO_000772 17667919 NP458969.RAdGbzMcfCa8MZXFzhlhDHmkT_C4uB1T3Q5X79741fic8130_provenance.
- NP458969.RAdGbzMcfCa8MZXFzhlhDHmkT_C4uB1T3Q5X79741fic8130_assertion wasDerivedFrom befree-20140225 NP458969.RAdGbzMcfCa8MZXFzhlhDHmkT_C4uB1T3Q5X79741fic8130_provenance.
- NP458969.RAdGbzMcfCa8MZXFzhlhDHmkT_C4uB1T3Q5X79741fic8130_assertion wasGeneratedBy ECO_0000203 NP458969.RAdGbzMcfCa8MZXFzhlhDHmkT_C4uB1T3Q5X79741fic8130_provenance.